Synthesis of Neolamellarin A, an Inhibitor of Hypoxia-inducible Factor-1

被引:0
作者
Arafeh, Khaled M. [1 ]
Ullah, Nisar [1 ]
机构
[1] King Fahd Univ Petr & Minerals, Dept Chem, Dhahran 31261, Saudi Arabia
关键词
hypoxia-inducible factor-1; antitumor agent; acylation; natural product; HIF-1; BLOCKADE; THERAPY; CANCER;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Neolamellarin A, a metabolite isolated from the sponge Dendrilla nigra, was found to inhibit hypoxia-inducible factor-1 (HIF-1) activation by 26% at 10 mu M concentration and inhibition of HIF-1 has become a major antitumour molecular target. Herein the first synthesis of neolamellarin A is described. The synthetic strategy features the condensation of vinylogous amide with aminomalonate to construct the 3,4-bis(4-methoxyphenyl)-1H-pyrrole core and the subsequent acylation and deprotection rendered the target compound in 18% over all yield.
引用
收藏
页码:925 / 926
页数:2
相关论文
共 10 条
  • [1] Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway
    Kung, AL
    Zabludoff, SD
    France, DS
    Freedman, SJ
    Tanner, EA
    Vieira, A
    Cornell-Kennon, S
    Lee, J
    Wang, BQ
    Wang, JM
    Memmert, K
    Naegeli, HU
    Petersen, F
    Eck, MJ
    Bair, KW
    Wood, AW
    Livingston, DM
    [J]. CANCER CELL, 2004, 6 (01) : 33 - 43
  • [2] MICHAEL S, 2008, ARCH PHARM, V341, P281
  • [3] Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity
    Moeller, BJ
    Dreher, MR
    Rabbani, ZN
    Schroeder, T
    Cao, YT
    Li, CY
    Dewhirst, MW
    [J]. CANCER CELL, 2005, 8 (02) : 99 - 110
  • [4] NOBORU O, 1998, J CHEM SOC P1, P1595
  • [5] RUI L, 2007, J NAT PRODUCTS, V70, P1741
  • [6] SANGHEE K, 2001, B KOREAN CHEM SOC, V22, P1403
  • [7] Development of novel therapeutic strategies that target HIF-1
    Semenza, GL
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2006, 10 (02) : 267 - 280
  • [8] Targeting HIF-1 for cancer therapy
    Semenza, GL
    [J]. NATURE REVIEWS CANCER, 2003, 3 (10) : 721 - 732
  • [9] The hypoxia-inducible factor-1α is a negative factor for tumor therapy
    Unruh, A
    Ressel, A
    Mohamed, HG
    Johnson, RS
    Nadrowitz, R
    Richter, E
    Katschinski, DM
    Wenger, RH
    [J]. ONCOGENE, 2003, 22 (21) : 3213 - 3220
  • [10] Hypoxia in cancer: significance and impact on clinical outcome
    Vaupel, Peter
    Mayer, Arnulf
    [J]. CANCER AND METASTASIS REVIEWS, 2007, 26 (02) : 225 - 239